220 related articles for article (PubMed ID: 31053968)
1. Molecular dynamics of fentanyl bound to μ-opioid receptor.
Lipiński PFJ; Jarończyk M; Dobrowolski JC; Sadlej J
J Mol Model; 2019 May; 25(5):144. PubMed ID: 31053968
[TBL] [Abstract][Full Text] [Related]
2. How μ-opioid receptor recognizes fentanyl.
Vo QN; Mahinthichaichan P; Shen J; Ellis CR
Nat Commun; 2021 Feb; 12(1):984. PubMed ID: 33579956
[TBL] [Abstract][Full Text] [Related]
3. Fentanyl Family at the Mu-Opioid Receptor: Uniform Assessment of Binding and Computational Analysis.
Lipiński PFJ; Kosson P; Matalińska J; Roszkowski P; Czarnocki Z; Jarończyk M; Misicka A; Dobrowolski JC; Sadlej J
Molecules; 2019 Feb; 24(4):. PubMed ID: 30791394
[TBL] [Abstract][Full Text] [Related]
4. Molecular docking reveals a novel binding site model for fentanyl at the mu-opioid receptor.
Subramanian G; Paterlini MG; Portoghese PS; Ferguson DM
J Med Chem; 2000 Feb; 43(3):381-91. PubMed ID: 10669565
[TBL] [Abstract][Full Text] [Related]
5. Steric interactions and the activity of fentanyl analogs at the mu-opioid receptor.
Dosen-Micovic L; Ivanovic M; Micovic V
Bioorg Med Chem; 2006 May; 14(9):2887-95. PubMed ID: 16376082
[TBL] [Abstract][Full Text] [Related]
6. To probe interaction of morphine and IBNtxA with 7TM and 6TM variants of the human μ-opioid receptor using all-atom molecular dynamics simulations with an explicit membrane.
Sader S; Anant K; Wu C
Phys Chem Chem Phys; 2018 Jan; 20(3):1724-1741. PubMed ID: 29265141
[TBL] [Abstract][Full Text] [Related]
7. Structural Assessment of Agonist Efficacy in the μ-Opioid Receptor: Morphine and Fentanyl Elicit Different Activation Patterns.
Ricarte A; Dalton JAR; Giraldo J
J Chem Inf Model; 2021 Mar; 61(3):1251-1274. PubMed ID: 33448226
[TBL] [Abstract][Full Text] [Related]
8. Ligand based conformational space studies of the μ-opioid receptor.
Sena DM; Cong X; Giorgetti A
Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129838. PubMed ID: 33373630
[TBL] [Abstract][Full Text] [Related]
9. Homology models of mu-opioid receptor with organic and inorganic cations at conserved aspartates in the second and third transmembrane domains.
Zhorov BS; Ananthanarayanan VS
Arch Biochem Biophys; 2000 Mar; 375(1):31-49. PubMed ID: 10683246
[TBL] [Abstract][Full Text] [Related]
10. Probing biased activation of mu-opioid receptor by the biased agonist PZM21 using all atom molecular dynamics simulation.
Liao S; Tan K; Floyd C; Bong D; Pino MJ; Wu C
Life Sci; 2021 Mar; 269():119026. PubMed ID: 33444617
[TBL] [Abstract][Full Text] [Related]
11. Molecular recognition of morphine and fentanyl by the human μ-opioid receptor.
Zhuang Y; Wang Y; He B; He X; Zhou XE; Guo S; Rao Q; Yang J; Liu J; Zhou Q; Wang X; Liu M; Liu W; Jiang X; Yang D; Jiang H; Shen J; Melcher K; Chen H; Jiang Y; Cheng X; Wang MW; Xie X; Xu HE
Cell; 2022 Nov; 185(23):4361-4375.e19. PubMed ID: 36368306
[TBL] [Abstract][Full Text] [Related]
12. Molecular modeling of mu opioid receptor and receptor-ligand interaction.
Rong SB; Zhu YC; Jiang HL; Zhao SR; Wang QM; Chi ZQ; Chen KX; Ji RY
Zhongguo Yao Li Xue Bao; 1997 Jul; 18(4):317-22. PubMed ID: 10072913
[TBL] [Abstract][Full Text] [Related]
13. ASP147 in the third transmembrane helix of the rat mu opioid receptor forms ion-pairing with morphine and naltrexone.
Li JG; Chen C; Yin J; Rice K; Zhang Y; Matecka D; de Riel JK; DesJarlais RL; Liu-Chen LY
Life Sci; 1999; 65(2):175-85. PubMed ID: 10416823
[TBL] [Abstract][Full Text] [Related]
14. Predicting opioid receptor binding affinity of pharmacologically unclassified designer substances using molecular docking.
Ellis CR; Kruhlak NL; Kim MT; Hawkins EG; Stavitskaya L
PLoS One; 2018; 13(5):e0197734. PubMed ID: 29795628
[TBL] [Abstract][Full Text] [Related]
15. Molecular Modeling of µ Opioid Receptor Ligands with Various Functional Properties: PZM21, SR-17018, Morphine, and Fentanyl-Simulated Interaction Patterns Confronted with Experimental Data.
Podlewska S; Bugno R; Kudla L; Bojarski AJ; Przewlocki R
Molecules; 2020 Oct; 25(20):. PubMed ID: 33053718
[TBL] [Abstract][Full Text] [Related]
16. Molecular modeling of mu opioid receptor and its interaction with ohmefentanyl.
Tang Y; Chen KX; Jiang HL; Wang ZX; Ji RY; Chi ZQ
Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):156-60. PubMed ID: 9772668
[TBL] [Abstract][Full Text] [Related]
17. How Oliceridine (TRV-130) Binds and Stabilizes a μ-Opioid Receptor Conformational State That Selectively Triggers G Protein Signaling Pathways.
Schneider S; Provasi D; Filizola M
Biochemistry; 2016 Nov; 55(46):6456-6466. PubMed ID: 27778501
[TBL] [Abstract][Full Text] [Related]
18. Opioid peptide receptor studies, 11: involvement of Tyr148, Trp318 and His319 of the rat mu-opioid receptor in binding of mu-selective ligands.
Xu H; Lu YF; Partilla JS; Zheng QX; Wang JB; Brine GA; Carroll FI; Rice KC; Chen KX; Chi ZQ; Rothman RB
Synapse; 1999 Apr; 32(1):23-8. PubMed ID: 10188634
[TBL] [Abstract][Full Text] [Related]
19. Interaction of p-fluorofentanyl on cloned human opioid receptors and exploration of the role of Trp-318 and His-319 in mu-opioid receptor selectivity.
Ulens C; Van Boven M; Daenens P; Tytgat J
J Pharmacol Exp Ther; 2000 Sep; 294(3):1024-33. PubMed ID: 10945855
[TBL] [Abstract][Full Text] [Related]
20. Key residues defining the mu-opioid receptor binding pocket: a site-directed mutagenesis study.
Mansour A; Taylor LP; Fine JL; Thompson RC; Hoversten MT; Mosberg HI; Watson SJ; Akil H
J Neurochem; 1997 Jan; 68(1):344-53. PubMed ID: 8978745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
